Graham Capital Management L.P. Makes New $3.25 Million Investment in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Graham Capital Management L.P. acquired 217,827 shares of DENTSPLY SIRONA Inc. valued at approximately $3.25 million, increasing its ownership to about 0.11% of the company.
• Analysts have given DENTSPLY SIRONA an average rating of "Hold" with a consensus price target of $18.64, with recent downgrades from some firms lowering their price targets.
• DENTSPLY SIRONA announced a quarterly dividend of $0.16 per share, representing an annualized yield of 4.5%, with the ex-dividend date set for September 26th.

Graham Capital Management L.P. acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 217,827 shares of the medical instruments supplier's stock, valued at approximately $3,254,000. Graham Capital Management L.P. owned 0.11% of DENTSPLY SIRONA at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of XRAY. Invenomic Capital Management LP increased its stake in DENTSPLY SIRONA by 201.0% during the fourth quarter. Invenomic Capital Management LP now owns 2,639,161 shares of the medical instruments supplier's stock worth $50,091,000 after purchasing an additional 1,762,428 shares during the period. Lazard Asset Management LLC grew its position in shares of DENTSPLY SIRONA by 23.0% during the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock worth $152,678,000 after buying an additional 1,505,928 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of DENTSPLY SIRONA by 11.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier's stock worth $208,590,000 after buying an additional 1,412,517 shares in the last quarter. Voloridge Investment Management LLC acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $24,571,000. Finally, D. E. Shaw & Co. Inc. boosted its holdings in DENTSPLY SIRONA by 936.9% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 997,415 shares of the medical instruments supplier's stock valued at $18,931,000 after purchasing an additional 901,224 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Wells Fargo & Company lowered their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a report on Friday, August 8th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Wall Street Zen cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. UBS Group cut their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Finally, Stifel Nicolaus lowered their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday, August 8th. Two analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Trading Up 0.7%

Shares of NASDAQ XRAY traded up $0.10 during midday trading on Wednesday, hitting $13.91. The stock had a trading volume of 2,389,400 shares, compared to its average volume of 3,670,340. The company has a market capitalization of $2.77 billion, a price-to-earnings ratio of -2.93, a PEG ratio of 0.89 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.48. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The company has a fifty day moving average price of $15.05 and a 200 day moving average price of $15.28.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company's revenue was down 4.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 4.6%. DENTSPLY SIRONA's payout ratio is -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.